NovaBridge Biosciences (NBP) Other Non-Current Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has reported Other Non-Current Assets for 8 consecutive years, with $2.8 million the latest figure, recorded in Q4 2025.

• Quarterly Other Non-Current Assets rose 106.01% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (up 106.01% YoY) and the FY2025 annual result came in at $2.8 million, up 106.01% from the prior year.
• Other Non-Current Assets advanced to $2.8 million in Q4 2025 per NBP's latest filing, from $1.1 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for NBP reached as high as $4.2 billion in Q4 2021 and fell as low as $464000.0 in Q2 2024.
• A 5-year average of $322.4 million and a median of $1.4 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2021 — Other Non-Current Assets surged 120462.8% — and 2022, when it tumbled 99.92%.
• Year by year, Other Non-Current Assets stood at $4.2 billion in 2021, then plunged by 99.92% to $3.5 million in 2022, then surged by 132.78% to $8.2 million in 2023, then slumped by 83.32% to $1.4 million in 2024, then soared by 106.01% to $2.8 million in 2025.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.8 million, $1.1 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.